Sofía M. Vera González
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Sofía M. Vera González has a total of 4 co-authors. Here are the top co-authors by number of shared publications:
- Brenda Ozón
Centro de Investigación de Proteínas Vegetales (CIPROVE), Departamento de Ciencias Biológicas, Facultad de Ciencias Exactas, Universidad Nacional de La Plata, Buenos Aires, Argentina
1 shared publication - Javier Garcia-Pardo
Departament de Bioquímica i Biologia Molecular, Universitat Autònoma de Barcelona, Bellaterra, 08193 Barcelona, Spain
1 shared publication - Mónica Graciela Parisi
Departamento de Ciencias Básicas, INEDES (CONICET-UNLu), Universidad Nacional de Luján, Luján, Argentina
1 shared publication - Walter David Obregón
Centro De Investigación De Proteínas Vegetales (CIPROVE), Departamento De Ciencias Biológicas, Facultad De Ciencias Exactas, Universidad Nacional De La Plata, 47 y 115 S/N, B1900AVW, La Plata, Argentina
1 shared publication
Latest Publications
- Open Access
- 24 April 2024
- Published by MDPI AG in Pharmaceutics
- Vol. 16 (5) , 582
Plant Protease Inhibitors as Emerging Antimicrobial Peptide Agents: A Comprehensive Review
Antimicrobial peptides (AMPs) are important mediator molecules of the innate defense mechanisms in a wide range of living organisms, including bacteria, mammals, and plants. Among them, peptide protease inhibitors (PPIs) from plants play a central role in their defense mechanisms by directly attacking pathogens or by modulating the plant’s defense response. The growing prevalence of microbial resistance to currently available antibiotics has intensified the interest concerning these molecules as novel antimicrobial agents. In this scenario, PPIs isolated from a variety of plants have shown potential in inhibiting the growth of pathogenic bacteria, protozoans, and fungal strains, either by interfering with essential biochemical or physiological processes or by altering the permeability of biological membranes of invading organisms. Moreover, these molecules are active inhibitors of a range of proteases, including aspartic, serine, and cysteine types, with some showing particular efficacy as trypsin and chymotrypsin inhibitors. In this review, we provide a comprehensive analysis of the potential of plant-derived PPIs as novel antimicrobial molecules, highlighting their broad-spectrum antimicrobial efficacy, specificity, and minimal toxicity. These natural compounds exhibit diverse mechanisms of action and often multifunctionality, positioning them as promising molecular scaffolds for developing new therapeutic antibacterial agents.
- 24 April 2024
- Published by MDPI AG in Pharmaceutics
- Vol. 16 (5) , 582
Open AccessPlant Protease Inhibitors as Emerging Antimicrobial Peptide Agents: A Comprehensive Review
Antimicrobial peptides (AMPs) are important mediator molecules of the innate defense mechanisms in a wide range of living organisms, including bacteria, mammals, and plants. Among them, peptide protease inhibitors (PPIs) from plants play a central role in their defense mechanisms by directly attacking pathogens or by modulating the plant’s defense response. The growing prevalence of microbial resistance to currently available antibiotics has intensified the interest concerning these molecules as novel antimicrobial agents. In this scenario, PPIs isolated from a variety of plants have shown potential in inhibiting the growth of pathogenic bacteria, protozoans, and fungal strains, either by interfering with essential biochemical or physiological processes or by altering the permeability of biological membranes of invading organisms. Moreover, these molecules are active inhibitors of a range of proteases, including aspartic, serine, and cysteine types, with some showing particular efficacy as trypsin and chymotrypsin inhibitors. In this review, we provide a comprehensive analysis of the potential of plant-derived PPIs as novel antimicrobial molecules, highlighting their broad-spectrum antimicrobial efficacy, specificity, and minimal toxicity. These natural compounds exhibit diverse mechanisms of action and often multifunctionality, positioning them as promising molecular scaffolds for developing new therapeutic antibacterial agents.